Where it's made
| Factory | Where | Role | Last FDA inspection |
|---|---|---|---|
| Glenmark Pharmaceuticals Limited | Dhar, India | Makes it and tests it | Serious problems, FDA actionFeb 14, 2025 · 8 inspections, 1 with FDA action |
Recalls
- Mar 13, 2025 · Class II · Glenmark Pharmaceuticals Inc., USA
CGMP Deviations
Lots: Lot # 17232024, exp. date Aug-25 17232071, exp. date Sep-25 17232072, exp. date Sep-25 - Mar 13, 2025 · Class II · Glenmark Pharmaceuticals Inc., USA
CGMP Deviations
Lots: Lot # 17232361, exp. date Nov-25 17232367, exp. date Nov-25 17240037, exp. date Dec-25 17240038, exp. date Dec-25
Class I recalls are the most serious; Class III the least. A recall covers specific lots, listed on each recall.
Product details
- Generic drug
- Nitroglycerin: every company that makes it
- Form
- tablet, sublingual
- Strength
- 0.6 mg
- Approval
- ANDA ANDA206391
- On the market since
- Sep 19, 2017
- Package NDCs
68462-640-01- Official label
- DailyMed (National Library of Medicine), updated Dec 26, 2025
Got it by mail or from a pharmacy you don't know? Look the pharmacy up on Who Filled My Rx?